IL220797A - Specific anti-angiogenic adenoviral agent and uses thereof - Google Patents
Specific anti-angiogenic adenoviral agent and uses thereofInfo
- Publication number
- IL220797A IL220797A IL220797A IL22079712A IL220797A IL 220797 A IL220797 A IL 220797A IL 220797 A IL220797 A IL 220797A IL 22079712 A IL22079712 A IL 22079712A IL 220797 A IL220797 A IL 220797A
- Authority
- IL
- Israel
- Prior art keywords
- specific anti
- angiogenic
- adenoviral agent
- agent
- angiogenic adenoviral
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL220797A IL220797A (en) | 2010-01-05 | 2012-07-05 | Specific anti-angiogenic adenoviral agent and uses thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28222810P | 2010-01-05 | 2010-01-05 | |
US28224710P | 2010-01-07 | 2010-01-07 | |
PCT/IL2011/000007 WO2011083464A2 (en) | 2010-01-05 | 2011-01-05 | Methods for use of a specific anti-angiogenic adenoviral agent |
IL220797A IL220797A (en) | 2010-01-05 | 2012-07-05 | Specific anti-angiogenic adenoviral agent and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
IL220797A0 IL220797A0 (en) | 2012-08-30 |
IL220797A true IL220797A (en) | 2017-03-30 |
Family
ID=47145897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL220797A IL220797A (en) | 2010-01-05 | 2012-07-05 | Specific anti-angiogenic adenoviral agent and uses thereof |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL220797A (en) |
-
2012
- 2012-07-05 IL IL220797A patent/IL220797A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL220797A0 (en) | 2012-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100032I1 (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
HK1187049A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
ZA201303600B (en) | Composition i-ii and products and uses thereof | |
EP2552953A4 (en) | Frizzled-binding agents and uses thereof | |
EP2622104A4 (en) | Mesothelioma biomarkers and uses thereof | |
HRP20160922T1 (en) | Oligopeptidic compounds and uses thereof | |
ZA201208173B (en) | Peptices and their use | |
EP2523974A4 (en) | Wnt-binding agents and uses thereof | |
HK1190070A1 (en) | Chemoembolization composition comprising anti-angiogenic agents | |
EP2582836A4 (en) | Prpk-tprkb modulators and uses thereof | |
HRP20182083T1 (en) | Novel combination and use | |
EP2608785A4 (en) | Lipomacrocycles and uses thereof | |
HK1173368A1 (en) | Pigmentation-preventing or-ameliorating agent | |
IL220808A (en) | Cooling and processingg materials | |
EP2529013A4 (en) | Novel -glucosidase and uses thereof | |
EP2615094A4 (en) | Sesterterpene compounds and use thereof | |
EP2412791A4 (en) | Solid cleaning composition and solid cleaning agent | |
IL220797A (en) | Specific anti-angiogenic adenoviral agent and uses thereof | |
EP2619580A4 (en) | Solution microarrays and uses thereof | |
GB201020268D0 (en) | Composition and uses | |
GB201017093D0 (en) | Biomarkers and uses thereof | |
EP2638160A4 (en) | Nuclions and ribocapsids | |
GB201014319D0 (en) | Compounds and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |